Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02220842
Title A Safety and Pharmacology Study of MPDL3280A Administered With Obinutuzumab in Patients With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | FRA | DEU

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
Fort Wayne Neurological Center Fort Wayne Indiana 46805 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Sloan Kettering Cancer Center New York New York 10065-6007 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
UW- Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
Hopital Claude Huriez - CHU Lille; Service des maladies du sang Lille 59037 France Details
Hopital Saint Eloi Montpellier 34295 France Details
Hôpital Saint-Louis Paris 75475 France Details
Centre Hospitalier Lyon Sud Pierre Benite 69495 France Details
Institut Gustave Roussy Villejuif 94805 France Details
Universitaetsklinikum Freiburg Freiburg 79106 Germany Details
Azienda Ospedaliera Città della Salute e della Scienza di Torino Torino Piemonte 10126 Italy Details
Barts Hospital London E1 2EF United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field